Avoro Capital Advisors LLC Intra Cellular Therapies, Inc. Transaction History
Avoro Capital Advisors LLC
- $6.65 Billion
- Q3 2024
A detailed history of Avoro Capital Advisors LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 3,050,000 shares of ITCI stock, worth $388 Million. This represents 3.36% of its overall portfolio holdings.
Number of Shares
3,050,000
Previous 3,000,000
1.67%
Holding current value
$388 Million
Previous $205 Million
8.54%
% of portfolio
3.36%
Previous 2.8%
Shares
4 transactions
Others Institutions Holding ITCI
# of Institutions
382Shares Held
84.5MCall Options Held
319KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA9.63MShares$1.22 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$803 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$672 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$489 Million1.4% of portfolio
-
Invesco Ltd. Atlanta, GA2.99MShares$380 Million0.04% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...